PL2579866T3 - Dopochwowe podawanie mizoprostolu - Google Patents

Dopochwowe podawanie mizoprostolu

Info

Publication number: PL2579866T3
Authority: PL; Poland
Prior art keywords: misoprostol; intravaginal administration; intravaginal; administration
Prior art date: 2010-06-11

Application number

PL11793311T

Other languages

English (en)

Inventor

Barbara L. Powers

La Cruz Vidal F. De

Steven Robertson

Original Assignee

Ferring B.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-06-11

Filing date

2011-06-13

Publication date

2017-01-31

2011-06-13 Application filed by Ferring B.V. filed Critical Ferring B.V.

2017-01-31 Publication of PL2579866T3 publication Critical patent/PL2579866T3/pl

Links

OJLOPKGSLYJEMD-URPKTTJQSA-N methyl 7-[(1r,2r,3r)-3-hydroxy-2-[(1e)-4-hydroxy-4-methyloct-1-en-1-yl]-5-oxocyclopentyl]heptanoate Chemical compound CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC OJLOPKGSLYJEMD-URPKTTJQSA-N 0.000 title 1
229960005249 misoprostol Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Reproductive Health (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Gynecology & Obstetrics (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Pregnancy & Childbirth (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)

PL11793311T 2010-06-11 2011-06-13 Dopochwowe podawanie mizoprostolu PL2579866T3 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US35383510P	2010-06-11	2010-06-11

Publications (1)

Publication Number	Publication Date
PL2579866T3 true PL2579866T3 (pl)	2017-01-31

Family

ID=45098734

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL11793311T PL2579866T3 (pl)	2010-06-11	2011-06-13	Dopochwowe podawanie mizoprostolu

Country Status (17)

Country	Link
US (1)	US20130197081A1 (pl)
EP (1)	EP2579866B1 (pl)
JP (2)	JP5964294B2 (pl)
KR (1)	KR101852913B1 (pl)
CN (1)	CN102939085B (pl)
AU (1)	AU2011265222B2 (pl)
CA (1)	CA2802214A1 (pl)
DK (1)	DK2579866T3 (pl)
ES (1)	ES2587260T3 (pl)
HU (1)	HUE028795T2 (pl)
IL (1)	IL223481B (pl)
MX (1)	MX339883B (pl)
NZ (1)	NZ604064A (pl)
PL (1)	PL2579866T3 (pl)
PT (1)	PT2579866T (pl)
RU (1)	RU2588671C2 (pl)
WO (1)	WO2011156812A2 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2011265222B2 (en) *	2010-06-11	2015-04-02	Ferring B.V.	Intravaginal administration of misoprostol
CN102302443B (zh) *	2011-09-21	2014-04-23	天津市聚星康华医药科技有限公司	一种米索前列醇阴道缓释栓剂及其制备方法
EP2689781A1 (en)	2012-07-26	2014-01-29	Ferring B.V.	Misoprostol composition
EP2754442A1 (en)	2013-01-09	2014-07-16	Ferring B.V.	Misoprostol for the induction of labour
EP2877181A1 (en) *	2012-07-26	2015-06-03	Ferring BV	Misprostol composition
EP2754443A1 (en)	2013-01-09	2014-07-16	Ferring B.V.	Misoprostol for the induction of labour
EA030124B1 (ru) *	2012-07-26	2018-06-29	Ферринг Б.В.	Способ уменьшения вероятности развития инфекции и применение интравагинального вкладыша по указанному назначению
EP2689802A1 (en)	2012-07-26	2014-01-29	Ferring B.V.	Misoprostol formulation
US20160008310A1 (en)	2014-07-11	2016-01-14	Azanta A/S	Misoprostol dispersible tablet
DK3166597T3 (en)	2014-07-11	2025-09-01	Azanta Danmark As	Misoprostol dispersibel tablet
WO2018009789A1 (en) *	2016-07-08	2018-01-11	Vanderbilt University	Treatment and prevention of clostridium difficile colitis using misoprostol
CN108753898A (zh) *	2018-04-09	2018-11-06	深圳市祥根生物科技有限公司	一种米索前列醇酸的制备方法及其用途
EP3935581A4 (en)	2019-03-04	2022-11-30	Iocurrents, Inc.	DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5017382A (en) *	1979-03-21	1991-05-21	National Research Development Corporation	Controlled release compositions (II)
US20020031513A1 (en) *	1997-11-24	2002-03-14	Shamir Leibovitz	Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals
GB0417401D0 (en) *	2004-08-05	2004-09-08	Controlled Therapeutics Sct	Stabilised prostaglandin composition
WO2006089561A1 (en) *	2005-02-23	2006-08-31	Abbas Abdelsalam Ghazi	Pharmaceutical compositions containing organic acids useful for softening and ripening uterine cervix.
US20090269480A1 (en) *	2008-04-24	2009-10-29	Medtronic Vascular, Inc.	Supercritical Fluid Loading of Porous Medical Devices With Bioactive Agents
WO2010036878A1 (en) *	2008-09-26	2010-04-01	The Trustees Of Columbia University In The City Of New York	Use of trpv1 receptor agonists in cervical pain and labor
RU2408375C1 (ru) *	2009-06-04	2011-01-10	Учреждение Российской академии медицинских наук Научно-исследовательский институт акушерства и гинекологии им. Д.О. Отта Северо-Западного отделения РАМН	Способ подготовки к родам беременных с преждевременным излитием околоплодных вод при доношенном сроке
AU2011265222B2 (en) *	2010-06-11	2015-04-02	Ferring B.V.	Intravaginal administration of misoprostol

2011
- 2011-06-13 AU AU2011265222A patent/AU2011265222B2/en not_active Ceased
- 2011-06-13 PT PT117933119T patent/PT2579866T/pt unknown
- 2011-06-13 US US13/702,747 patent/US20130197081A1/en not_active Abandoned
- 2011-06-13 ES ES11793311.9T patent/ES2587260T3/es active Active
- 2011-06-13 WO PCT/US2011/040202 patent/WO2011156812A2/en not_active Ceased
- 2011-06-13 CA CA2802214A patent/CA2802214A1/en not_active Abandoned
- 2011-06-13 HU HUE11793311A patent/HUE028795T2/en unknown
- 2011-06-13 NZ NZ604064A patent/NZ604064A/en not_active IP Right Cessation
- 2011-06-13 RU RU2012154445/15A patent/RU2588671C2/ru not_active IP Right Cessation
- 2011-06-13 DK DK11793311.9T patent/DK2579866T3/en active
- 2011-06-13 PL PL11793311T patent/PL2579866T3/pl unknown
- 2011-06-13 JP JP2013514412A patent/JP5964294B2/ja not_active Expired - Fee Related
- 2011-06-13 KR KR1020137000723A patent/KR101852913B1/ko not_active Expired - Fee Related
- 2011-06-13 CN CN201180028801.3A patent/CN102939085B/zh not_active Expired - Fee Related
- 2011-06-13 EP EP11793311.9A patent/EP2579866B1/en not_active Not-in-force
- 2011-06-13 MX MX2012014413A patent/MX339883B/es active IP Right Grant
2012
- 2012-12-06 IL IL223481A patent/IL223481B/en not_active IP Right Cessation
2016
- 2016-03-16 JP JP2016051955A patent/JP6262787B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DK2579866T3 (en)	2016-08-29
AU2011265222A1 (en)	2013-05-23
PT2579866T (pt)	2016-08-19
RU2012154445A (ru)	2014-07-20
NZ604064A (en)	2014-10-31
EP2579866A2 (en)	2013-04-17
JP5964294B2 (ja)	2016-08-03
EP2579866B1 (en)	2016-05-18
CN102939085B (zh)	2016-05-04
JP6262787B2 (ja)	2018-01-17
EP2579866A4 (en)	2013-12-04
US20130197081A1 (en)	2013-08-01
WO2011156812A3 (en)	2012-04-19
KR20130109099A (ko)	2013-10-07
JP2016164167A (ja)	2016-09-08
HK1184059A1 (zh)	2014-01-17
ES2587260T3 (es)	2016-10-21
HUE028795T2 (en)	2017-01-30
MX2012014413A (es)	2013-02-26
MX339883B (es)	2016-06-16
CA2802214A1 (en)	2011-12-15
AU2011265222B2 (en)	2015-04-02
KR101852913B1 (ko)	2018-04-27
CN102939085A (zh)	2013-02-20
WO2011156812A2 (en)	2011-12-15
RU2588671C2 (ru)	2016-07-10
IL223481B (en)	2018-11-29
JP2013528231A (ja)	2013-07-08

Publication	Publication Date	Title
PL2579866T3 (pl)	2017-01-31	Dopochwowe podawanie mizoprostolu
SG10201506840QA (en)	2015-10-29	Cytotoxicity-inducing therapeutic agent
GB201010193D0 (en)	2010-07-21	Medicinal use
EP2629786A4 (en)	2015-08-05	COMPOSITIONS FOR THE ADMINISTRATION OF MEDICAMENTS
ZA201209407B (en)	2013-08-28	Modification of xylan
IL226298A (en)	2017-06-29	Intra-vaginal devices for controlled lubrication
PT3415139T (pt)	2022-06-20	Administração de benzodiazepina
SI2741824T1 (sl)	2017-06-30	Uporaba estetrola kot urgentnega kontracepcijskega sredstva
SMT202000229T1 (it)	2020-07-08	Nuova forma di somministrazione di racecadotril
EP2552210A4 (en)	2014-01-15	FORMULAS FROM MAZINDOL
IL223437B (en)	2018-04-30	Secreting condom
EP2605795A4 (en)	2015-06-10	INTRAVAGINAL DEVICES AND METHOD FOR THEIR MANUFACTURE AND USE
SI2407155T1 (sl)	2013-04-30	Preparati na osnovi inekalcitola
PT2536400E (pt)	2014-11-27	Medicamento contendo myramistin
GB201001203D0 (en)	2010-03-10	Use of pharmaceutically active compounds
PL390434A1 (pl)	2011-08-16	Preparat leczniczy
GB201003727D0 (en)	2010-04-21	Therapeutic agent
GB201003342D0 (en)	2010-04-14	Manufacture of insoluble drugs
TWM402097U (en)	2011-04-21	Improved condom structure
GB201001317D0 (en)	2010-03-17	Medicament
PL390620A1 (pl)	2011-09-12	Preparat farmaceutyczny
TWM389548U (en)	2010-10-01	Improved structure of soft capsule
AU332227S (en)	2010-08-17	Therapeutic pillow
AU2010900699A0 (en)	2010-03-04	Therapeutic Uses of SLIRP
GB201010577D0 (en)	2010-08-11	Therapeutic agents